EUVIMEDSkopri EUVIMED
Open access · CC BY 4.0

Electromechanical modelling and simulation of human‐induced pluripotent stem cell‐derived cardiomyocytes predict drug‐induced contractility effects

Milda Folkmanaite iD, Xin Zhou iD, Andreas Koschinski iD, Wan-Hua Hong, Marilù Casini iD, Manuel Koch iD, Ursula Ravens iD, Remi Peyronnet iD, Manuela Zaccolo, Blanca Rodriguez

The Journal of Physiology · 2026-07 · 604 (13) · 5629-5662

DOI: 10.1113/jp288623 ↗

At a glance

Journal article in The Journal of Physiology, published online on 2026-03-11. Written by Milda Folkmanaite and 9 co-authors. Institution: University of Oxford, Oxford, United Kingdom. Major MEDLINE topics: Myocytes, Cardiac, Induced Pluripotent Stem Cells, Myocardial Contraction, Models, Cardiovascular. Cited 1 times so far (Crossref); 95 references. The full text is freely available (open access, CC BY 4.0). Funded by: National Centre for the Replacement Refinement and Reduction of Animals in Research, Oxford-Bristol Myers Squibb Fellowship, Marie Sklodowska-Curie.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Human‐induced pluripotent stem cell‐derived cardiomyocytes (hiPSC‐CMs) hold promise in personalized medicine, particularly for cardiac diseases and human‐data‐based pharmacology studies. Assessing hiPSC‐CM mechanics and their changes in response to drug action in silico enables more efficient drug testing. For such investigations, hiPSC‐CMs also provide a versatile alternative to adult human cardiac tissue which is limited in availability for research. To enable in silico investigations of hiPSC‐CM electrophysiology and contraction, we developed and evaluated two versions of hiPSC‐CM electromechanical models with different maturation states. The models were based solely on human cardiomyocyte and hiPSC‐CM data. The evaluation process involved comparing simulation outcomes with an extensive dataset of experimental data to ensure the reliability of the model within the context of hiPSC‐CM pharmacology studies. The models uniquely incorporated the mechanical properties of hiPSC‐CMs, providing insights into the mechanisms underlying their contractile behaviour. In our in silico studies, we simulated the effects of 64 different drugs, including those with previously untested inotropic effects. We demonstrated agreement between the simulation and experimental datasets, correctly identifying the inotropic effects of 41 out of 48 drugs. We also compared the effect of pharmacological agents with unknown inotropic effects and conducted novel experiments demonstrating agreement with simulation outcomes. Finally, using the models, we demonstrated the mechanisms of previously unrecognized rate‐dependent inotropic effects of paliperidone. Altogether this study presents an in vitro – in silico framework which is evaluated against experimental data and allows for simulating drug‐dependent electromechanical effects with high accuracy and prediction of rate‐dependent inotropic effects. image Key points Human‐induced pluripotent stem cell‐derived cardiomyocytes (hiPSC‐CMs) are promising for drug testing and disease modelling, but current computer models that allow us to simulate hiPSC‐CM behaviour lack human‐specific mechanical properties. We developed and validated hiPSC‐CM electromechanical models, allowing accurate simulations of contraction, calcium signalling and electrophysiology for two different maturation stages. Simulations with the new models correctly predicted inotropic effects for 41 out of 48 drugs and identified previously unknown effects of two drugs, later confirmed experimentally. Simulations revealed novel rate‐dependent inotropic effects of paliperidone linked to calcium handling differences in paced versus non‐paced cells. This in silico framework can enhance drug testing accuracy and understanding through mechanistic studies by integrating experimental data with computational predictions.

Subjects

MeSH terms (MEDLINE)

Myocytes, CardiacInduced Pluripotent Stem CellsMyocardial ContractionModels, CardiovascularHumansComputer Simulation

Author keywords

cardiomyocytecardiovascular physiologycomputer modellingstem cell

Authors and institutions

  • University of Oxford, Oxford, United Kingdom.
  • University of Turin, Turin, Italy.
  • Institute for Experimental Cardiovascular Medicine, University Heart Center Freiburg - Bad Krozingen, Medical Center - University of Freiburg and Faculty of Medicine, University of Freiburg, Freiburg, Germany.

ORCID profiles: Milda Folkmanaite, Xin Zhou, Andreas Koschinski, Marilù Casini, Manuel Koch, Ursula Ravens, Remi Peyronnet

Funding

  • National Centre for the Replacement Refinement and Reduction of Animals in Research
  • Oxford-Bristol Myers Squibb Fellowship
  • Marie Sklodowska-Curie
  • British Heart Foundation
  • Wellcome Trust

Cite

APA

Folkmanaite, M., Zhou, X., Koschinski, A., Hong, W. H., Casini, M., Koch, M., Ravens, U., Peyronnet, R., Zaccolo, M., & Rodriguez, B. (2026). Electromechanical modelling and simulation of human‐induced pluripotent stem cell‐derived cardiomyocytes predict drug‐induced contractility effects. The Journal of Physiology, 604(13), 5629-5662. https://doi.org/10.1113/jp288623

Vancouver

Folkmanaite M, Zhou X, Koschinski A, Hong WH, Casini M, Koch M, et al. Electromechanical modelling and simulation of human‐induced pluripotent stem cell‐derived cardiomyocytes predict drug‐induced contractility effects. The Journal of Physiology. 2026;604(13):5629-5662. doi:10.1113/jp288623

BibTeX
@article{Folkmanaite2026,
  author = {Folkmanaite, Milda and Zhou, Xin and Koschinski, Andreas and Hong, Wan-Hua and Casini, Marilù and Koch, Manuel and Ravens, Ursula and Peyronnet, Remi and Zaccolo, Manuela and Rodriguez, Blanca},
  title = {Electromechanical modelling and simulation of human‐induced pluripotent stem cell‐derived cardiomyocytes predict drug‐induced contractility effects},
  journal = {The Journal of Physiology},
  year = {2026},
  volume = {604},
  number = {13},
  pages = {5629--5662},
  doi = {10.1113/jp288623}
}
Start for free →